Deficiency in the Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3 Increases Sensitivity to Mood Disturbances

被引：190

作者：

Polter, Abigail ^{[1
,2
]}

Beurel, Eleonore ^{[1
]}

Yang, Sufen ^{[1
]}

Garner, Rakesha ^{[1
]}

Song, Ling ^{[1
]}

Miller, Courtney A. ^{[2
]}

Sweatt, J. David ^{[2
]}

McMahon, Lori ^{[2
,3
]}

Bartolucci, Alfred A. ^{[4
]}

Li, Xiaohua ^{[2
]}

Jope, Richard S. ^{[1
]}

机构：

[1] Univ Alabama, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA

[2] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA

[3] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA

[4] Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA

来源：

NEUROPSYCHOPHARMACOLOGY | 2010年 / 35卷 / 08期

关键词：

bipolar disorder; glycogen synthase kinase-3; depression; amphetamine; lithium; ASSESSING ANTIDEPRESSANT ACTIVITY; FORCED SWIM TEST; BIPOLAR DISORDER; ALZHEIMERS-DISEASE; PSYCHOTROPIC-DRUGS; RAT HIPPOCAMPUS; GENE-EXPRESSION; PROTEIN-LEVELS; MOUSE MODEL; DEPRESSION;

D O I：

10.1038/npp.2010.43

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Bipolar disorder, characterized by extreme manic and depressive moods, is a prevalent debilitating disease of unknown etiology. Because mood stabilizers, antipsychotics, antidepressants, and mood-regulating neuromodulators increase the inhibitory serine-phosphorylation of glycogen synthase kinase-3 (GSK3), we hypothesized that deficient GSK3 serine-phosphorylation may increase vulnerability to mood-related behavioral disturbances. This was tested by measuring behavioral characteristics of GSK3 alpha/beta(21A/21A/9A/9A) knockin mice with serine-to-alanine mutations to block inhibitory serine-phosphorylation of GSK3. GSK3 knockin mice displayed increased susceptibility to amphetamine-induced hyperactivity and to stress-induced depressive-like behaviors. Furthermore, serine-phosphorylation of GSK3 was reduced during both mood-related behavioral responses in wild-type mouse brain and in blood cells from patients with bipolar disorder. Therefore, proper control of GSK3 by serine-phosphorylation, which is targeted by agents therapeutic for bipolar disorder, is an important mechanism that regulates mood stabilization, and mice with disabled GSK3 serine-phosphorylation may provide a valuable model to study bipolar disorder. Neuropsychopharmacology (2010) 35, 1761-1774; doi:10.1038/npp.2010.43; published online 31 March 2010

引用

页码：1761 / 1774

页数：14

共 58 条

[1] Ventral hippocampal lesions affect anxiety but not spatial learning [J].

Bannerman, DM ;

Grubb, M ;

Deacon, RMJ ;

Yee, BK ;

Feldon, J ;

Rawlins, JNP .

BEHAVIOURAL BRAIN RESEARCH, 2003, 139 (1-2) :197-213

[2] Role of GSK3β in behavioral abnormalities induced by serotonin deficiency [J].

Beaulieu, Jean-Martin ;

Zhang, Xiaodong ;

Rodriguiz, Ramona M. ;

Sotnikova, Tatyana D. ;

Cools, Michael J. ;

Wetsel, William C. ;

Gainetdinov, Raul R. ;

Caron, Marc G. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (04) :1333-1338

[3] Akt/GSK3 Signaling in the Action of Psychotropic Drugs [J].

Beaulieu, Jean-Martin ;

Gainetdinov, Raul R. ;

Caron, Marc G. .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2009, 49 :327-347

[4] Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade [J].

Beaulieu, JM ;

Sotnikova, TD ;

Yao, WD ;

Kockeritz, L ;

Woodgett, JR ;

Gainetdinov, RR ;

Caron, MG .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) :5099-5104

[5] Reduced insulin-induced phosphatidylinositol-3-kinase activation in peripheral blood mononuclear leucocytes from patients with Alzheimer's disease [J].

Castri, Paola ;

Iacovelli, Luisa ;

De Blasi, Antonio ;

Giubilei, Franco ;

Moretti, Arianna ;

Capone, Francesca Tari ;

Nicoletti, Ferdinando ;

Orzi, Francesco .

EUROPEAN JOURNAL OF NEUROSCIENCE, 2007, 26 (09) :2469-2472

[6] The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3 [J].

Chen, G ;

Huang, LD ;

Jiang, YM ;

Manji, HK .

JOURNAL OF NEUROCHEMISTRY, 1999, 72 (03) :1327-1330

[7] Automated tests for measuring the effects of antidepressants in mice [J].

Crowley, JJ ;

Jones, MD ;

O'Leary, OF ;

Lucki, I .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 78 (02) :269-274

[8] The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice [J].

Cryan, JF ;

Mombereau, C ;

Vassout, A .

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2005, 29 (4-5) :571-625

[9] Assessing antidepressant activity in rodents: recent developments and future needs [J].

Cryan, JF ;

Markou, A ;

Lucki, I .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (05) :238-245

[10] From inflammation to sickness and depression: when the immune system subjugates the brain [J].

Dantzer, Robert ;

O'Connor, Jason C. ;

Freund, Gregory G. ;

Johnson, Rodney W. ;

Kelley, Keith W. .

NATURE REVIEWS NEUROSCIENCE, 2008, 9 (01) :46-57

← 1 2 3 4 5 6 →